1Research progress in evidence-based medicine of IgA nephropathy in 2022CHEN Pei, LYU Ji-chengSYMPOSIUM?EVALUATION AND TREATMENT OF IMMUNE-RELATED KIDNEY DISEASE177-1822Progress of primary membranous nephropathy in diagnosis and treatmentWU Min, WEI Qing, LIU Bi-chengSYMPOSIUM?EVALUATION AND TREATMENT OF IMMUNE-RELATED KIDNEY DISEASE183-1873Focusing on atypical hemolytic uremic syndromeYUE Cai, CHEN Li-mengSYMPOSIUM?EVALUATION AND TREATMENT OF IMMUNE-RELATED KIDNEY DISEASE188-1924Application progress of biologics in immune-related renal diseaseZHANG Mo, YAO LiSYMPOSIUM?EVALUATION AND TREATMENT OF IMMUNE-RELATED KIDNEY DISEASE193-1975Expert recommendations on the early screening path of adult chronic kidney disease and its complications in China(2023 edition)TANG Xi, SHI Yun-ying, WANG Jian-qin, LU Chen, ZHOU Zhu, ZHA Yan, FU Rong-guo, WANG Li-hua, WANG Cai-li, ZHOU Xiao-ling, DU Xiao-gang, WANG Ting-li, DUAN Di-fei, FU PingEXPERT ADVICE198-2056Expert recommendations on renal anemia management process for maintenance hemodialysisExpert Panel on Chronic Kidney Disease Management Recommendations for Primary Health-care ProvidersEXPERT ADVICE206-2097Interpretation of Guidelines for the management of chronic heart failure in dialysis patients in ChinaSUN Xue-fengSPECIFICATION AND INTERPRETATION210-217,2308Management of vascular calcification in patients with moderate to advanced stage chronic kidney diseaseCHENG HongEXPERT FORUM218-2249Factors influencing the long-term improvement of renal function in patients with renal artery stenosisXU Xiao-yi, WANG Guo-qin, CHENG Hong, YANG Lei, YE Nan, CHENG Wen-rong, ZHANG Lei, YONG Qiang, GUO XiORIGINAL CONTRIBUTION225-23010Analysis of the difference in therapeutic effect of hypoxic-inducible factor prolyl hydroxylase inhibitor in the treatment of renal anemia in maintenance hemodialysis patientsZHAO Peng, WANG Ze-kai, GUO Lan, WU Fan, LUO Ke, DONG Chun-xia, NIU Kai, LIU BingORIGINAL CONTRIBUTION231-235,24611Clinical study on the relationship between non-ABL1 kinase domain mutation and TKI drug resistance and disease progression in chronic myeloid leukemiaWANG Xian-wei, ZHOU Ling, LI Yang-wei, ZOU Zhe, SONG Yun-feng, WANG Lin-lin, ZHANG Yan-li, LYU Xiao-dongORIGINAL CONTRIBUTION236-24012Effect of hemoglobin variability on residual renal function in patients on initial hemodialysisKANG Zhe, WANG Jin-ling, XIE Hua, SUN Yan-ling, ZHANG Sheng-kun, YU Chun-xinORIGINAL CONTRIBUTION241-246 